Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jun 26, 2022 3:11pm
Mugsy is really shorting
he just pumps to lure in investors .Mugsy is a clown.
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Jun 26, 2022 10:22am
RE:RE:RE:RE:Interesting
9 years later how is the progress
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jun 26, 2022 6:57am
RE:RE:RE:RE:Interesting
Ten Years later .....still dreams and pies in the sky and no food on the table
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 25, 2022 10:28pm
RE:RE:RE:Interesting
Interesting ... if we look back at the 2013 preliminary prespectus, we see ... 1. 346 - Naproxen identified for OA, RA, Ankylosing Spondylitis, dysmenorrhea, dental pain and general pain. 2
...more
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Jun 25, 2022 8:26pm
RE:RE:Should You Sell Biotech Stocks If There's a Recession?
No one is buying the pump. Lost money on just abut every dollar you threw in here lol
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Jun 25, 2022 5:14pm
RE:Q4 last year was end of june
Another useless post from the dumpster. We know it's going to be June 29th for 2022. again this guy brings nothing to the table except videos and trolling comments. He's only here to
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 24, 2022 11:00pm
Q4 last year was end of june
Antibe Therapeutics Earnings Date & Reports FollowPortfolio Earnings Data
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 24, 2022 10:30pm
RE:Should You Sell Biotech Stocks If There's a Recession?
Thanks for sharing Davgro. Risk tolerance is the key here - it certainly won't be for everyone ... but ... there are a few really good points to consider. For risk-tolerant investors, recessions
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 24, 2022 9:33pm
RE:RE:If 2021 is any indication ...
Perfect - thanks Davgro ! --------------------------------------------------------
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Jun 24, 2022 9:18pm
RE:If 2021 is any indication ...
The following is an excerpt from today's Thomson Reuters StockReports+ for ATE. They have listed the next expected report date as June 29th, 2022.
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Jun 24, 2022 8:44pm
Should You Sell Biotech Stocks If There's a Recession?
Interesting read from yesterday on the Motley Fool site. https://www.fool.com/investing/2022/06/23/should-you-sell-biotech-stocks-if-theres-a-recessi/
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Jun 24, 2022 8:29pm
RE:RE:ATE is in blackout
I finally decided to put all the trolls on Ignore. I was engaging with the Dumpster for awhile but that became tiresome and I have quickly learned [again] that you can't fix stupid.
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jun 24, 2022 7:30pm
If 2021 is any indication ...
Going into the last week of June ! It was on the last Monday of June 2021 that we received the financials and an update. It never seems to work out the same ... but ... conditions are similar in 2022
...more
(8)
•••
TechMoose
X
View Profile
View Bullboard History
Comment by
TechMoose
on Jun 24, 2022 6:29pm
RE:RE:RE:ATE is in blackout
Thanks Magic. Such a pathetic amount of dribble that these accounts put out. Appreciate you putting the list together so I can put them on ignore. Adding absolutely no value whatsoever.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 24, 2022 2:24pm
we got a minnow on the line
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >